Stains & CD markers
Tpit


Last author update: 24 August 2022
Last staff update: 1 February 2023

Copyright: 2022-2023, PathologyOutlines.com, Inc.

PubMed Search: Tpit

William McDonald, M.D.
Page views in 2022: 411
Page views in 2023 to date: 81
Cite this page: McDonald W. Tpit. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/stainsTpit.html. Accessed February 3rd, 2023.
Definition / general
  • Pituitary adenomas / pituitary neuroendocrine tumors have traditionally been classified using a combination of immunohistochemical stains for anterior pituitary hormones, including stains for prolactin, growth hormone, thyrotropin (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), adrenocorticotropic hormone (ACTH) and the alpha subunit (ASU) of the glycoprotein hormones
  • Immunostains for anterior pituitary transcription factors steroidogenic factor 1 (SF1), Pit1 and T box transcription factor (Tpit) have been shown to have higher sensitivity and specificity than hormone IHC stains and are often used in conjunction to classify pituitary adenomas
  • Transcription factor Tpit drives corticotroph differentiation; IHC for Tpit is useful in identifying corticotroph adenomas
  • Immunohistochemical stains for Tpit identify nonneoplastic corticotrophs within the anterior pituitary and both silent and functioning corticotroph adenomas
Essential features
  • Tpit IHC shows strong nuclear staining
  • Tpit is expressed within anterior pituitary gland corticotroph cells and within corticotroph adenomas
  • Tpit IHC is more sensitive and specific than IHC stain for ACTH
Terminology
  • T box transcription factor (Tpit)
  • Gene name: T box transcription factor 19 (TBX19)
Pathophysiology
  • Terminal differentiation of corticotrophs is controlled by transcription factor Tpit
  • Germline mutations of TBX19 cause isolated ACTH deficiency (J Mol Endocrinol 2016;56:T99)
Diagrams / tables

Contributed by William McDonald, M.D.
SF1 drives gonadotroph lineage

Tpit drives corticotroph lineage

Clinical features
  • Most corticotroph adenomas are hormonally functional microadenomas
  • Functional adenomas tend to be smaller; corticotroph macroadenomas are often hormonally silent
Interpretation
  • Nuclear expression is evaluated (reactivity only in the cytoplasm is regarded as negative)
  • Tpit immunoreactivity in corticotroph adenoma is typically diffuse, strong and nuclear (score 7 or 8 in the Allred scale) (Mod Pathol 1998;11:155)
  • Immunoreactivity in anterior pituitary gland (nonneoplastic anterior pituitary) shows moderate to strong nuclear staining in scattered adenohypophysis cells, within occasional clusters of cells and often in grouped cells associated with the pituitary stalk (so called basophil invasion); corticotrophs are a minority population within the adenohypophysis
Uses by pathologists
Prognostic factors
Microscopic (histologic) images

Contributed by William McDonald, M.D.

Normal adenohypophysis

Normal adenohypophysis
(reticulin)

Normal adenohypophysis
(Tpit)

Corticotroph adenoma

Corticotroph adenoma
(Tpit)


Corticotroph adenoma
(SF1)

Corticotroph adenoma
(Pit1)

Corticotroph adenoma
(ACTH)

Corticotroph adenoma
(CAM5.2)

Corticotroph adenoma
(GATA3)

Positive staining - normal
Positive staining - disease
Negative staining
Sample pathology report
  • Sella turcica, resection:
    • Pituitary adenoma (pituitary neuroendocrine tumor), corticotroph type (see comment)
    • Comment: This tumor shows diffuse nuclear immunoreactivity for Tpit and no immunoreactivity for SF1 or Pit1. Moderate ACTH immunoreactivity is observed, as is diffuse, strong staining for PAS and immunoreactivity for low molecular cytokeratin CAM5.2, supporting the impression. In the context of a microadenoma with clinical signs and symptoms of Cushing disease, this is a corticotroph adenoma (densely granulated subtype).
    • Clinical information (mandatory to include): The patient presented with a 6 month history of central obesity, diabetes mellitus, hypertension and thin skin with striae; magnetic resonance imaging showed a 4 mm hypoenhancing mass within the pituitary gland.
    • Available preoperative endocrine testing (also mandatory): Midnight salivary cortisol levels were elevated; tests for prolactin, TSH, free T4 and IGF1 were normal.
Board review style question #1

A 48 year old woman presents with bitemporal vision loss. MRI reveals a 2.5 cm sellar and suprasellar tumor, which compresses the optic chiasm. No signs or symptoms or Cushing disease or other hormone excess are present clinically. Transphenoidal resection confirms pituitary adenoma by H&E stains. The adenoma shows immunohistochemical staining as illustrated above. How is this adenoma best classified?

  1. Corticotroph adenoma
  2. Gonadotroph adenoma
  3. Null cell adenoma
  4. Prolactinoma
Board review style answer #1
A. Corticotroph adenoma. This clinically silent corticotroph adenoma became symptomatic when it compressed the optic apparatus, a common presentation for large pituitary macroadenomas. Strong, diffuse nuclear immunoreactivity for Tpit, along with characteristically pale immunoreactivity for ACTH and strong, diffuse cytoplasmic staining for CAM5.2 support the diagnosis. Gonadotroph adenomas (answer B), while often presenting in similar fashion as clinically nonfunctioning macroadenoma, would have SF1 immunoreactivity and lack staining for Tpit. Null cell adenoma (answer C) by definition lacks hormone or transcription factor immunostaining. Prolactinoma (answer D) would also lack Tpit staining and would show strong nuclear immunoreactivity for transcription factor Pit1.

Comment Here

Reference: Tpit
Back to top
Image 01 Image 02